<DOC>
	<DOCNO>NCT01541527</DOCNO>
	<brief_summary>Antibodies ( Abs ) direct factorVIII ( FVIII ) remain main iatrogenic complication haemophilia A ( HA ) patient . Anti-FVIII Abs inhibit pro-coagulant property molecule name inhibitor whereas Abs direct towards non-functional epitope name non-neutralizing antibody ( NNA ) . These NNA poorly study prevalence ill-defined . In recent retrospective study investigator evaluate , cohort 210 patient without inhibitor , NNA prevalence NNA epitope specificity heavy chain ( HC ) light chain ( LC ) . For first time , investigator use two x-MAP base assay : first determine specificity anti-FVIII Abs HC LC , second display Abs direct towards B domain . NNA find 38 210 patient ( 18 ) . Among NNA positive population , 74 % 13 % patient anti-FVIII Abs chain . The proportion NNA direct towards B domain 18 % . Considering approximate inhibitor prevalence 30 % NNA prevalence 19 % severe HA patient , approximately 50 % severe HA patient develop immune response infuse FVIII . Due unclear relevance , NNA detection yet belong routine clinical practice . However , 2006 , Dimichele advancedf hypothesis concern influence NNA variation kinectics FVIII observe certain patient . The mechanism explain role NNA FVIII FVIII kinectics still demonstrate . The investigator propose perform multicentre prospective study aim confirm , severe , moderate mild HA treat patietns , NNA prevalence observe retrospective study , study evolution time epitopemapping NNA explore correlation NNA clinical/biological parameter .</brief_summary>
	<brief_title>Non Neutralizing Antibodies : Prevalence Characterization</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>male Age &gt; 6 year Severe , moderate mild treat HA patient negative inhibitor titer ( &lt; 0.6UB ) An information form present patient his/her legal representative physician include patient study protocol Patient national insurance Patient without agreement study Patient deprive freedom Patient without national insurance</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>non neutralize antibody</keyword>
	<keyword>Epitopic profile</keyword>
	<keyword>Clinical relevance</keyword>
</DOC>